Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Literature
1.
Wang Q, Cao B, Peng L, et al. Development and validation of a practical prognostic coagulation index for patients with esophageal squamous cell cancer. Ann Surg Oncol. 2021;28(13):8450–61.CrossRefPubMed
2.
Song Q, Wu JZ, Wang S, Chen WH. Elevated preoperative platelet distribution width predicts poor prognosis in esophageal squamous cell carcinoma. Sci Rep. Oct 23 2019;9(1):15234.
3.
Matsunaga T, Saito H, Fukumoto Y, et al. The postoperative platelet distribution width is useful for predicting the prognosis in patients with esophageal squamous cell carcinoma. Surg Today. 2020;50(2):123–33.CrossRefPubMed
4.
Kawakita Y, Motoyama S, Sato Y, et al. Prognostic significance of combined platelet distribution width and C-reactive protein score in esophageal cancer. Anticancer Res. 2020;40(10):5715–25.CrossRefPubMed
5.
Xia W, Chen W, Tu J, Ni C, Meng K. Prognostic value and clinicopathologic features of platelet distribution width in cancer: a meta-analysis. Med Sci Monit. 2018;24:7130–6.CrossRefPubMedPubMedCentral
Metadata
Title
Does Pretreatment Platelet Distribution Width Predict Prognosis in Esophageal Cancer?
Author
Yan Wang, MD
Publication date
25-08-2022
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 13/2022
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-022-12478-0

Other articles of this Issue 13/2022

Annals of Surgical Oncology 13/2022 Go to the issue

ASO Author Reflections

ASO Author Reflections: Identification of High-Performing Veterans Affairs Health System Regions to Improve Patient Outcomes of Veterans with Hepatocellular Carcinoma

ASO Author Reflections

ASO Author Reflections: Is it Correct to Use 5% Dextrose Solution as a Carrier Fluid for Oxaliplatin-based HIPEC?

ASO Author Reflections

ASO Author Reflections: Challenges in the Management of Bowel Obstruction after Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy

Peritoneal Surface Malignancy

Pharmacologic Effects of Oxaliplatin Instability in Chloride-Containing Carrier Fluids on the Hyperthermic Intraperitoneal Chemotherapy to Treat Colorectal Cancer In Vitro and In Vivo

ASO Visual Abstract

ASO Visual Abstract: Who Are We Missing: Does Engagement in Patient-Reported Outcome Measures for Breast Cancer Vary by Age, Race, and Disease Stage?

ASO Author Reflections

ASO Author Reflections: Avoiding Overtreatment: Benefits of Selective Use of Frozen Sections Among cN0 Breast Cancer Patients Having Upfront Mastectomy